Epstein Secrets

e House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modena, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios <https://www.axios.com/us-biden- vaccine-patents-waiver-65478c91-5107-41ff-

accine Is Effective Against Variants. The New York Times <https://www.nytimes.com/2021/05/05/health/coronavirus-pfizer-vaccine-variants.html> (5/5, Anthes, 20.6M) reports that two new studies "showed the [Pfizer-BioNTech] vaccine to be more than 95 percent effective at protecting against severe disease

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, induding Moderna, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufact

that the booster shots did not produce excessive side effects. Pfizer Studies Show Vaccine Is Effective Against Variants. The New York Times (5/5, Anthes, 20.6M) reports that two new studies "showed the [Pfizer- BioNTech] vaccine to be more than 95 percent effective at protecting against severe disease

accines' Efficacy For Teens Could Boost Inoculations. USA Today (5/6, Bacon, 12.7M) reports that "encouraging data" recently released by Moderna and Pfizer "on the effectiveness and safety of COVID-19 vaccines for kids" may "ignite much-needed momentum in the lagging national vaccination effort, expert

e Trump Administration will provide some momentum." Studies Suggest Pfizer And Moderna Vaccines Protect Against Variants. The New York Times (5/6, Anthes, Otterman, Mandavilli, Waller, 20.6M) reports that "several new studies released on Wednesday offered encouraging news about the ability of widely u

do more activities socially. I do think it's going to make a big difference in opening our society back up." The AP (5/25, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6- month-old babies." Reuters (5/25, Steenhuysen) reports that FDA reg

as it was on Tuesday." EFTA00148336 OTHER WASHINGTON NEWS Moderna Announces COVID Vaccine Is Effective For Teenagers. The New York Times (5/25, Anthes, 20.6M) reports that Moderna "said on Tuesday that its coronavirus vaccine, authorized only for use in adults, was powerfully effective in 12- to 17

House in the fight to end the pandemic." But "stocks of major pharmaceutical companies that have produced vaccines, including Modema, BioNTech and Pfizer, dropped sharply after news of the potential waivers first broke." Axios (5/5, Baker, 1.26M) says a waiver "would open the door for foreign manufac

that the booster shots did not produce excessive side effects. Pfizer Studies Show Vaccine Is Effective Against Variants. The New York Times (5/5, Anthes, 20.6M) reports that two new studies "showed the [Pfizer- BioNTech] vaccine to be more than 95 percent effective at protecting against severe disease

accines' Efficacy For Teens Could Boost Inoculations. USA Today (5/6, Bacon, 12.7M) reports that "encouraging data" recently released by Moderna and Pfizer "on the effectiveness and safety of COVID-19 vaccines for kids" may "ignite much-needed momentum in the lagging national vaccination effort, expert

e Trump Administration will provide some momentum." Studies Suggest Pfizer And Moderna Vaccines Protect Against Variants. The New York Times (5/6, Anthes, Otterman, Mandavilli, Waller, 20.6M) reports that "several new studies released on Wednesday offered encouraging news about the ability of widely u

o do more activities socially. I do think it's going to make a big difference in opening our society back up." The AP (5/25, Neergaard) reports that Pfizer and Moderna "have begun testing in even younger children, from age 11 down to 6-month-old babies." Reuters (5/25, Steenhuysen) reports that FDA reg

ts ugly facets as it was on Tuesday." OTHER WASHINGTON NEWS Moderna Announces COVID Vaccine Is Effective For Teenagers. The New York Times (5/25, Anthes, 20.6M) reports that Moderna "said on Tuesday that its coronavirus vaccine, authorized only for use in adults, was powerfully effective in 12- to 17